by NES | Oct 29, 2019 | Uncategorized
We are elated to report that today we have got IRB approval for a clinical trial for our surgical guidance software for percutaneous ablation of liver cancer. The trial will be conducted at the Dartmouth Hitchcock Medical Center. The guidance software is designed to...
by NES | Oct 4, 2019 | Entrepreneurship
I am glad to report that we have been admitted to the NIH Commercialization Acceleration Program or NIH CAP. Through this program NIH enhances commercialization opportunities for selected companies that have received SBIR Phase II funding. The program is run in...
